Makindo Medical Notes"One small step for man, one large step for Makindo" |
![]() |
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Emergency Drugs |Emergency Drug Antidotes |Emergency Cardiac Drugs |Emergency Endocrine Drugs |Emergency Gastrointestinal Drugs |Emergency Haematology Drugs |Emergency Neuropsychiatric drugs |Emergency Pain drugs |Emergency Respiratory drugs |Emergency Obstetric and Gynaecology Drugs |Emergency Paediatric Drugs
🧪 MOA: Replenishes glutathione stores, serves as a glutathione substitute, and enhances sulfate conjugation of acetaminophen (paracetamol).
💉 Dose IV: 150 mg/kg in 200 mL D5W over 1 hr, then 50 mg/kg in 500 mL D5W over 4 hrs, then 100 mg/kg in 1 L D5W over 16 hrs (21 total hrs; may need continuous LFTs and APAP level until liver enzymes normalise).
💊 Dose PO: 140 mg/kg ×1, then 70 mg/kg every 4h ×17 doses (72 hrs total).
🎯 Indication: Paracetamol overdose.
⚠️ Notes: Hypersensitivity reactions (consider switching to PO or slowing infusion). Can occur with PO. Pregnancy B.
🧪 MOA: Acts on A1 receptors in AV node, causing transient AV block.
💉 Dose IV: 6 mg rapid IV push; if no effect, 12 mg IV every 2 min ×2.
🎯 Indication: Stable SVT / stable narrow‑complex tachycardia.
⚠️ Notes: Avoid in pre‑existing 2nd/3rd‑degree AV block without pacing; can be pro‑arrhythmic. Pregnancy C.
🧪 MOA: Selective β2‑agonist.
💨 Dose Neb: 2.5–5 mg every 20 min for 1st hour, then 2.5–10 mg every 1–4 hrs PRN (alt: 10–15 mg over 1 hr).
🎯 Indication: Acute bronchospasm; hyperkalaemia.
⚠️ Notes: Hypokalaemia, tachycardia, hyperglycaemia. Pregnancy C.
🧪 MOA: Class III (K⁺ efflux blocker) with Class I/II/IV effects.
💉 Dose IV: Pulseless VF/VT: 300 mg IV push, then 150 mg IV push if needed. Stable wide‑complex tachy: 150 mg IV over 10 min, then 1 mg/min ×6 hrs, then 0.5 mg/min.
🎯 Indication: Pulseless VT/VF; wide‑complex tachyarrhythmias.
⚠️ Notes: Hypotension; pro‑arrhythmic risk. Pregnancy D.
🧪 MOA: Antimuscarinic (anticholinergic).
💉 Dose IV: OP/carbamate toxicity: 1–6 mg every 3–5 min PRN until secretions stop. Bradycardia (adult): 0.5 mg every 3–5 min (max 3 mg).
🎯 Indication: OP/carbamate poisoning; bradycardia.
⚠️ Notes: Avoid in hyperthermia and tachyarrhythmias. Pregnancy C.
🧪 MOA: Increases serum calcium; stabilises cardiac myocytes.
💉 Dose IV: 10% solution (1 g per 10 mL).
🎯 Indication: Hyperkalaemia; hypocalcaemia with dysrhythmia.
⚠️ Notes: CaCl more potent than gluconate; CaCl peripherally → severe phlebitis (prefer CVC). Pregnancy C.
🧪 MOA: Enhances GABAergic inhibition.
💉 Dose IV/IM: 2–10 mg every 6h PRN. 💊 PO: 2–10 mg every 6h PRN.
🎯 Indication: Seizure abortion; alcohol withdrawal; agitation; muscle spasm.
⚠️ Notes: Respiratory depression; hypotension. Pregnancy D.
🧪 MOA: Non‑DHP Ca²⁺ channel blocker; slows AV conduction.
💉 Dose IV: 0.25 mg/kg once; may repeat 0.35 mg/kg after 15 min; infusion 5–15 mg/hr.
🎯 Indication: AF with RVR; stable SVT.
⚠️ Notes: Hypotension; bradycardia. Pregnancy C.
🧪 MOA: β1 > β2 agonist.
💉 Dose IV: 2–20 mcg/kg/min.
🎯 Indication: Decompensated HF; refractory hypotension.
⚠️ Notes: Tachycardia; hypotension if hypovolaemic; PVCs. Pregnancy B.
🧪 MOA: α1, β1, dopaminergic agonist (dose dependent).
💉 Dose IV: <5 mcg/kg/min = dopaminergic; 5–10 = β; 10–20 = α.
🎯 Indication: Decompensated HF; hypotension.
⚠️ Notes: Tachyarrhythmias; tissue necrosis if extravasation (prefer CVC). Pregnancy C.
🧪 MOA: Dopamine antagonist / α‑antagonist.
💉 Dose IV: 1.25–2.5 mg every 4h PRN.
🎯 Indication: Antiemetic; migraine abortion.
⚠️ Notes: QT prolongation (torsades risk); NMS; EPS. Pregnancy C.
🧪 MOA: α/β agonist.
💉 Dose: ACLS: 1 mg 1:10,000 IV (PALS: 0.01 mg/kg). Anaphylaxis: 0.1–0.5 mg 1:1,000 IM. Hypotension: 1–10 mcg/min IV.
🎯 Indication: Anaphylaxis; cardiac arrest algorithms; severe asthma.
⚠️ Notes: Dosing errors; tissue necrosis; arrhythmias. Pregnancy C.
🧪 MOA: Potentiates ATIII; inhibits Xa > IIa.
💉 Dose SQ: 1 mg/kg every 12h or 1.5 mg/kg every 24h.
🎯 Indication: PE; NSTEMI; unstable angina.
⚠️ Notes: Monitor anti‑Xa if renal impairment/obesity; neuraxial procedures contraindicated. Pregnancy B.
🧪 MOA: Selective β1‑blocker.
💉 Dose IV: 500 mcg/kg load; 50–300 mcg/kg/min infusion.
🎯 Indication: Aortic dissection.
⚠️ Notes: May precipitate CHF; hypotension; bronchospasm. Pregnancy C.
🧪 MOA: PPI (H⁺/K⁺ ATPase inhibitor).
💉 Dose IV: 80 mg bolus then 8 mg/hr infusion.
🎯 Indication: Non‑variceal upper GI bleed.
⚠️ Notes: Generally well tolerated acutely. Pregnancy B.
🧪 MOA: GABA‑mimetic hypnosis.
💉 Dose IV: 0.3 mg/kg.
🎯 Indication: RSI induction.
⚠️ Notes: Possible adrenal suppression; lowers seizure threshold. Pregnancy C.
🧪 MOA: Opioid μ‑agonist.
💉 Dose IV: 25–100 mcg every 1–2h (~1 mcg/kg).
🎯 Indication: Analgesia; sedation adjunct.
⚠️ Notes: Respiratory depression; hypotension (vasodilation); laryngospasm. Pregnancy C.
🧪 MOA: Alcohol dehydrogenase inhibitor.
💉 Dose IV: 15 mg/kg load; then 10 mg/kg every 12h ×4; then 15 mg/kg every 12h until EG <20 mg/dL and asymptomatic with normal pH.
🎯 Indication: Methanol / ethylene glycol toxicity.
⚠️ Notes: Generally safe. Pregnancy C.
🧪 MOA: Voltage‑gated Na⁺ channel stabiliser.
💉 Dose IV: 15–20 mg/kg load at 150 mg/min.
🎯 Indication: Status epilepticus.
⚠️ Notes: Rapid admin → hypotension/arrhythmias; cardiac monitoring required. Pregnancy D.
🧪 MOA: Loop diuretic (Na⁺/Cl⁻ reabsorption inhibition).
💉 Dose IV: 20–40 mg initially; reassess; up to 200 mg single dose.
🎯 Indication: Pulmonary oedema; CHF exacerbation; hyperkalaemia (if diuresis).
⚠️ Notes: Volume depletion; hypokalaemia; metabolic alkalosis; ototoxicity. Pregnancy C.
🧪 MOA: ↑cAMP independent of β‑receptor; gluconeogenesis & glycogenolysis.
💉 Dose IV/IM/SQ: β‑blocker/CCB tox: 3–10 mg load then 1–10 mg/hr. Hypoglycaemia: 1 mg.
🎯 Indication: β‑blocker or CCB toxicity; hypoglycaemia.
⚠️ Notes: Anaphylactoid reactions; hypotension; emesis (aspiration risk). Pregnancy B.
🧪 MOA: Dopamine (D1/D2) antagonist.
💉 Dose PO/IM/IV: 5–10 mg every 2h (max 100 mg/day). Elderly: start 1 mg IM.
🎯 Indication: Agitation; psychosis.
⚠️ Notes: Dementia‑psychosis warning; NMS/EPS; QT prolongation. Pregnancy C.
🧪 MOA: Potentiates ATIII; inhibits thrombin and factors IX, X, XI, XII.
💉 Dose IV: VTE: 80 u/kg bolus then 18 u/kg/hr. ACS/AF: 60 u/kg bolus then 12 u/kg/hr.
🎯 Indication: VTE; ACS (LMWH preferred in NSTEMI).
⚠️ Notes: Bleeding risk; protamine reverses. Pregnancy C.
🧪 MOA: Glucocorticoid/mineralocorticoid effects.
💉 Dose IV: Adrenal crisis: 100 mg bolus then 50 mg every 6h ×24h then taper. Septic shock: 50 mg every 6h. Status asthmaticus: 1–2 mg/kg every 6h ×24h then maintenance.
🎯 Indication: Adrenal insufficiency; severe asthma; vasopressor‑refractory shock.
⚠️ Notes: Immunosuppression; hyperglycaemia. Pregnancy C.
🧪 MOA: Opioid μ‑agonist.
💉 Dose IV: 1–2 mg every 3–6h.
🎯 Indication: Analgesia.
⚠️ Notes: Respiratory depression; hypotension. 1 mg IV ≈ 7 mg IV morphine. Pregnancy C.
🧪 MOA: ↑Peripheral glucose uptake; shifts K⁺ intracellularly.
💉 Dose IV: HyperK: 5–10 units once. CCB OD: 1 u/kg bolus + 25 g dextrose if BG <250; then 0.1–1 u/kg/hr with dextrose to maintain BG 100–200 mg/dL. DKA/HHS: 0.1 u/kg bolus + 0.1 u/kg/hr infusion.
🎯 Indication: Hyperkalaemia; CCB overdose; DKA/HHS.
⚠️ Notes: Hypokalaemia; hypoglycaemia. Only regular insulin IV. Pregnancy B.
🧪 MOA: NMDA receptor antagonist.
💉 Dose IV: Analgesia (sub‑dissociative): 0.1–0.5 mg/kg. Procedural: 0.5–1 mg/kg. RSI: 2 mg/kg.
🎯 Indication: Analgesia; procedural sedation; RSI induction.
⚠️ Notes: Emergence reactions (treat with benzo); laryngospasm; ↑IOP/↑ICP; tachycardia; hypertension. Pregnancy D.
🧪 MOA: α1/β1/β2 antagonist.
💉 Dose IV: Bolus 20–80 mg every 10 min PRN; infusion 1–8 mg/min.
🎯 Indication: Hypertensive emergency.
⚠️ Notes: CHF exacerbation; bradycardia; bronchospasm. Pregnancy C.
🧪 MOA: Enhances GABAergic inhibition.
💉 Dose IV: Bolus 1–2 mg; infusion 1–10 mg/hr.
🎯 Indication: Delirium tremens; status epilepticus; serotonin syndrome; agitation.
⚠️ Notes: Respiratory depression; hypotension. Pregnancy D.
🧪 MOA: Modulates neuromuscular and cardiac excitability.
💉 Dose IV: Eclampsia: 2–4 g over 5 min. Torsades: 2 g push. Asthma: 2 g over 15 min.
🎯 Indication: Torsades/ventricular arrhythmias; status asthmaticus; eclampsia.
⚠️ Notes: Hypotension; respiratory depression. Pregnancy A.
🧪 MOA: Osmotic diuretic.
💉 Dose IV: 1 g/kg once.
🎯 Indication: Elevated ICP; impending herniation.
⚠️ Notes: Dehydration risk; osmotic nephrosis.
🧪 MOA: Ultra‑short‑acting barbiturate (sedation/hypnosis).
💉 Dose IV: 1 mg/kg, then 0.5 mg/kg every 2–5 min PRN.
🎯 Indication: Procedural sedation.
⚠️ Notes: Laryngospasm (treat with more methohexital); respiratory depression; hypotension. Pregnancy B.
🧪 MOA: Glucocorticoid/mineralocorticoid effects.
💉 Dose IV: Asthma: 1 mg/kg. Allergy: 1 mg/kg. PCP PNA: 30 mg IV BID ×5 days then taper.
🎯 Indication: Severe asthma; PCP pneumonia with A–a gradient >35 or PaO2 <70; acute hypersensitivity reaction.
⚠️ Notes: Immunosuppression; hyperglycaemia. Pregnancy C.
🧪 MOA: Dopamine antagonist in chemoreceptor trigger zone.
💉 Dose IV: 10 mg every 6h PRN.
🎯 Indication: Vomiting prevention and treatment.
⚠️ Notes: Tardive dyskinesia/EPS; dystonia; methaemoglobinaemia. Pregnancy B.
🧪 MOA: Benzodiazepine; GABA potentiation.
💉 Dose IV: RSI: 0.1 mg/kg. Infusion: 1–10 mg/hr. Procedural: 0.02–0.04 mg/kg.
🎯 Indication: Seizure abortion; procedural/ventilator sedation; RSI.
⚠️ Notes: Respiratory depression; hypotension. Pregnancy D.
🧪 MOA: Opioid μ‑agonist.
💉 Dose IV: 2–10 mg every 2–6h (~0.1 mg/kg).
🎯 Indication: Analgesia.
⚠️ Notes: Respiratory depression; hypotension (vasodilation). Pregnancy C.
🧪 MOA: Dihydropyridine Ca²⁺ blocker selective for cerebral arteries.
💊 Dose PO: 60 mg every 4h.
🎯 Indication: Subarachnoid haemorrhage.
⚠️ Notes: Hypotension (minimised by selectivity). Pregnancy C.
🧪 MOA: Venodilator; ↑cGMP.
💉 Dose IV: 5–200 mcg/min; increase by 10 mcg every 3–5 min to effect (often higher for pulmonary oedema).
🎯 Indication: CHF; angina.
⚠️ Notes: Hypotension; methaemoglobinaemia. Pregnancy C.
🧪 MOA: Direct vasodilator; NO donor.
💉 Dose IV: Start 0.3 mcg/kg/min; titrate to effect; max 10 mcg/kg/min.
🎯 Indication: Hypertensive emergency.
⚠️ Notes: Cyanide toxicity; methaemoglobinaemia; hypotension. Pregnancy C.
🧪 MOA: α1 > β1 agonist.
💉 Dose IV: 1–30 mcg/min.
🎯 Indication: Hypotension refractory to IV fluids.
⚠️ Notes: Tachyarrhythmias; tissue necrosis if extravasation (prefer CVC). Pregnancy C.
🧪 MOA: Splanchnic vasoconstriction; ↓ portal pressure.
💉 Dose IV/SQ: Variceal bleed: 50 mcg IV bolus, then 50 mcg/hr infusion. Sulfonylurea tox: 50 mcg SQ every 6h PRN.
🎯 Indication: Bleeding oesophageal varices; sulfonylurea toxicity.
⚠️ Notes: May precipitate biliary disease. Pregnancy B.
🧪 MOA: Antagonist at dopamine, histamine, α1, and 5‑HT2 receptors.
💉 Dose IM: 5–10 mg/day (max 30 mg/day). 💊 ODT: 5–10 mg/day (max 30 mg/day).
🎯 Indication: Agitation; psychosis.
⚠️ Notes: Not for dementia‑related psychosis; NMS/EPS; orthostatic hypotension; QT prolongation; no IV form. Pregnancy C.
🧪 MOA: 5‑HT3 receptor antagonist (central).
💉 Dose IV: 4–8 mg every 4–6h PRN.
🎯 Indication: Nausea/vomiting prevention and treatment.
⚠️ Notes: QT prolongation; torsades (rare). Pregnancy B.
🧪 MOA: Barbiturate causing sedation/hypnosis.
💉 Dose IV: 20 mg/kg once; may repeat 5–10 mg/kg in 20 min (max 30 mg/kg). Max infusion 50 mg/min.
🎯 Indication: Status epilepticus.
⚠️ Notes: Respiratory depression; hypotension. Pregnancy D.
🧪 MOA: Various glucocorticoid/mineralocorticoid effects.
💊 Dose PO: 1 mg/kg/day (usual 5–60 mg based on response).
🎯 Indication: Asthma exacerbation; PCP pneumonia (A–a >35 or PaO2 <70); allergic reaction.
⚠️ Notes: Immunosuppression; GI ulcer/perforation; hyperglycaemia. Pregnancy C.
🧪 MOA: GABAA agonist; Na⁺ channel blocker.
💉 Dose IV: Procedural: 1 mg/kg bolus, then 0.5 mg/kg every 3 min; RSI: 1.5–2.5 mg/kg; Vent sedation: 5–50 mcg/kg/min.
🎯 Indication: Procedural sedation; RSI induction; ventilator sedation.
⚠️ Notes: Hypotension; anaphylaxis; bradycardia; apnoea. Pregnancy B.
🧪 MOA: Ionically binds heparin.
💉 Dose IV: 1 mg neutralises 100 u heparin (max 50 mg) at 5 mg/min.
🎯 Indication: Heparin‑induced bleeding.
⚠️ Notes: Anaphylaxis (history of prior use/fish allergy); rapid infusion → hypotension. Pregnancy C.
🧪 MOA: Non‑depolarisng neuromuscular blocker.
💉 Dose IV: 1 mg/kg.
🎯 Indication: RSI paralysis.
⚠️ Notes: Prolonged paralysis. Pregnancy B.
🧪 MOA: Increases serum bicarbonate; increases buffer stores.
💉 Dose IV: HyperK/metabolic acidosis: 50 mEq once. TCA OD: 1–2 mEq/kg bolus. Salicylate tox: 3 amps (150 mEq) in 1 L D5W; bolus then infusion to maintain urine pH 7.5–8.
🎯 Indication: Hyperkalaemia; TCA toxicity; salicylate toxicity; metabolic acidosis.
⚠️ Notes: Caution in CHF; risk of metabolic alkalosis/hypernatraemia. Pregnancy C.
🧪 MOA: Depolarising neuromuscular blocker.
💉 Dose: 1.5 mg/kg IV (or 3–4 mg/kg IM).
🎯 Indication: RSI paralysis.
⚠️ Notes: Hyperkalaemia risk; subacute burn/crush injury (↑K); glaucoma (↑IOP); ↑ICP. Pregnancy C.